Field & Main Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,725
Closed -$171K 202
2019
Q3
$171K Sell
1,725
-200
-10% -$19K 0.15% 101
2019
Q2
$178K Sell
1,925
-1,735
-47% -$165K 0.16% 101
2019
Q1
$345K Buy
+3,660
New +$320K 0.33% 85
2018
Q3
$426K Hold
4,766
0.38% 79
2018
Q2
$429K Sell
4,766
-100
-2% -$8.3K 0.39% 79
2018
Q1
$434K Sell
4,866
-2,405
-33% -$231K 0.42% 77
2017
Q4
$759K Buy
+7,271
New +$820K 0.73% 46
2015
Q2
$723K Sell
6,250
-75
-1% -$8.57K 0.69% 57
2015
Q1
$729K Buy
6,325
+250
+4% +$29.9K 0.67% 60
2014
Q4
$680K Sell
6,075
-2,025
-25% -$214K 0.64% 65
2014
Q3
$768K Buy
8,100
+2,480
+44% +$224K 0.72% 61
2014
Q2
$965K Sell
5,620
-5,170
-48% -$393K 0.9% 50
2014
Q1
$753K Buy
10,790
+350
+3% +$27.7K 0.73% 61
2013
Q4
$882K Buy
+10,440
New +$826K 0.86% 48

Other funds holding CELG

Field & Main Bank's CELG Position: Q4 2019 in Review

Field & Main Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,725 shares — an estimated $171K sold.

Field & Main Bank first reported a position in CELG in Q4 2013 and held it in 14 quarters. The position peaked at $965K in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Field & Main Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Field & Main Bank sold 1,725 Celgene Corp shares in Q4 2019, an estimated $171K.
  • Field & Main Bank first reported a position in Celgene Corp in Q4 2013 and held it in 14 quarters.
  • Field & Main Bank's Celgene Corp position peaked at $965K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Field & Main Bank's 13F filing for Q4 2019, filed 3 Feb 2020.